DLEU1 and hepatocellular carcinoma: Our published study showed that miR‐133a expression was down‐regulated in HCC, and functioned as tumour suppressor in HCC progression.18 Moreover, the present study demonstrated that miR‐133a inhibitor partially reversed the inhibitory effect caused by DLEU1 depletion.